QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 189 filers reported holding QIAGEN NV in Q2 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $25,602,000 | +1486.2% | 913,670 | +1453.2% | 0.01% | +800.0% |
| Q3 2016 | $1,614,000 | +33.6% | 58,824 | +6.1% | 0.00% | – |
| Q2 2016 | $1,208,000 | +21.0% | 55,425 | +24.0% | 0.00% | – |
| Q1 2016 | $998,000 | -20.2% | 44,683 | -1.2% | 0.00% | – |
| Q4 2015 | $1,250,000 | -55.8% | 45,209 | -58.7% | 0.00% | -100.0% |
| Q3 2015 | $2,827,000 | +61.4% | 109,560 | +54.0% | 0.00% | 0.0% |
| Q2 2015 | $1,752,000 | +63.1% | 71,164 | +67.1% | 0.00% | – |
| Q1 2015 | $1,074,000 | -46.9% | 42,588 | -51.0% | 0.00% | -100.0% |
| Q4 2014 | $2,022,000 | +126.4% | 86,887 | +121.6% | 0.00% | – |
| Q3 2014 | $893,000 | -8.9% | 39,217 | -3.1% | 0.00% | – |
| Q2 2014 | $980,000 | +16.3% | 40,467 | +0.6% | 0.00% | – |
| Q1 2014 | $843,000 | -11.6% | 40,206 | -1.7% | 0.00% | – |
| Q4 2013 | $954,000 | -7.2% | 40,906 | -14.2% | 0.00% | – |
| Q3 2013 | $1,028,000 | +6.1% | 47,673 | -3.5% | 0.00% | – |
| Q2 2013 | $969,000 | – | 49,413 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
| Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
| Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
| Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
| Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
| Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
| CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
| Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
| PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |